Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc symbols : NVAX save search
North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
covid vaccine growth covid-19
European Vaccines Market 2020-2026 by Type, Disease, Administration, Patient, and Country
Published: 2021-06-10 (Crawled : 19:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.01%
H: 0.01%
C: -1.26%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.05%
H: 0.12%
C: -0.25%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -0.09%
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
|
| O: -0.21%
H: 3.31%
C: 2.53%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.49%
H: 0.03%
C: -0.61%
disease europe vaccine
Global Preventive Vaccines Market by Type, Disease, Administration, Patient, and Region 2020-2026
Published: 2021-06-09 (Crawled : 22:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.25%
H: 0.95%
C: 0.65%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.76%
H: 0.98%
C: 0.95%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.21%
H: 1.07%
C: 0.67%
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
|
| O: -1.89%
H: 3.4%
C: -0.36%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.94%
H: 1.27%
C: 1.2%
disease vaccine
Global Coronavirus (COVID-19) Vaccines Markets, 2019-2020 & 2027: Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed, RNA, DNA, Genetics
Published: 2021-06-04 (Crawled : 00:20) - prnewswire.com
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
| Email alert
Add to watchlist
ARCT 4 | $27.93 3.22% 3.11% 310K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
| Email alert
Add to watchlist
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
covid genetic vaccine repurposed
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.